Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M301924200 on July 1, 2003

J. Biol. Chem., Vol. 278, Issue 37, 35159-35167, September 12, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
278/37/35159    most recent
M301924200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Howard, M.
Right arrow Articles by Welch, W. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Howard, M.
Right arrow Articles by Welch, W. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Mammalian Osmolytes and S-Nitrosoglutathione Promote {Delta}F508 Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Protein Maturation and Function*

Marybeth Howard {ddagger} §, Horst Fischer ¶, Jeremie Roux ||, Bento C. Santos **, Steven R. Gullans {ddagger}{ddagger}, Paul H. Yancey §§ and William J. Welch {ddagger} ¶¶

From the {ddagger}Department of Surgery and the ||Department of Anesthesia, Surgical Research Laboratory, University of California, San Francisco, California 94110, the Children's Hospital Oakland Research Institute, Oakland, California 94609, the **Renal Division, Department of Medicine, Escola Paulista de Medicina, UNIFESP, 04023-900 Sao Paulo, Brazil, the {ddagger}{ddagger}Laboratory of Functional Genomics, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115, the §§Department of Biology, Whitman College, Walla Walla, Washington 99362, and the ¶¶Department of Medicine and Physiology, University of California, San Francisco, California 94110

In cystic fibrosis, the absence of functional CFTR results in thick mucous secretions in the lung and intestines, as well as pancreatic deficiency. Although expressed at high levels in the kidney, mutations in CFTR result in little or no apparent kidney dysfunction. In an effort to understand this phenomenon, we analyzed {Delta}F508 CFTR maturation and function in kidney cells under conditions that are common to the kidney, namely osmotic stress. Kidney cells were grown in culture and adapted to 250 mM NaCl and 250 mM urea. High performance liquid chromatography analysis of lysates from kidney cells adapted to these conditions identified an increase in the cellular osmolytes glycerophosphorylcholine, myo-inositol, sorbitol, and taurine. In contrast to isoosmotic conditions, hyperosmotic stress led to the proper folding and processing of {Delta}F508 CFTR. Furthermore, three of the cellular osmolytes, when added individually to cells, proved effective in promoting the proper folding and processing of the {Delta}F508 CFTR protein in both epithelial and fibroblast cells. Whole-cell patch clamping of osmolyte-treated cells showed that {Delta}F508 CFTR had trafficked to the plasma membrane and was activated by forskolin. Encouraged by these findings, we looked at other features common to the kidney that may impact {Delta}F508 maturation and function. Interestingly, a small molecule, S-nitrosoglutathione, which is a substrate for gamma glutamyltranspeptidase, an abundant enzyme in the kidney, likewise promoted {Delta}F508 CFTR maturation and function. S-Nitrosoglutathione-corrected {Delta}F508 CFTR exhibited a shorter half-life as compared with wild type CFTR. These results demonstrate the feasibility of a small molecule approach as a therapeutic treatment in promoting {Delta}F508 CFTR maturation and function and suggest that an additional treatment may be required to stabilize {Delta}F508 CFTR protein once present at the plasma membrane. Finally, our observations may help to explain why {Delta}F508 homozygous patients do not present with kidney dysfunction.


Received for publication, February 24, 2003 , and in revised form, June 4, 2003.

* This work was supported by National Institutes of Health Grants GM33551, DK51829, and 1P50HL60288, by the American Lung Association, and by the Cystic Fibrosis Research Institute. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ To whom correspondence should be addressed: Dept. of Surgery, University of California at San Francisco, 1001 Potrero Ave., Bldg. 1, Rm. 210, San Francisco, CA 94110. Tel.: 415-206-6884; Fax: 415-206-6997; E-mail: mbh1{at}itsa.ucsf.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Respir. Cell Mol. Bio.Home page
R. Bartoszewski, A. Rab, A. Jurkuvenaite, M. Mazur, J. Wakefield, J. F. Collawn, and Z. Bebok
Activation of the Unfolded Protein Response by {Delta}F508 CFTR
Am. J. Respir. Cell Mol. Biol., October 1, 2008; 39(4): 448 - 457.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Bartoszewski, A. Rab, G. Twitty, L. Stevenson, J. Fortenberry, A. Piotrowski, J. P. Dumanski, and Z. Bebok
The Mechanism of Cystic Fibrosis Transmembrane Conductance Regulator Transcriptional Repression during the Unfolded Protein Response
J. Biol. Chem., May 2, 2008; 283(18): 12154 - 12165.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
K. Zaman, S. Carraro, J. Doherty, E. M. Henderson, E. Lendermon, L. Liu, G. Verghese, M. Zigler, M. Ross, E. Park, et al.
S-Nitrosylating Agents: A Novel Class of Compounds That Increase Cystic Fibrosis Transmembrane Conductance Regulator Expression and Maturation in Epithelial Cells
Mol. Pharmacol., October 1, 2006; 70(4): 1435 - 1442.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
B. Gaston, D. Singel, A. Doctor, and J. S. Stamler
S-Nitrosothiol Signaling in Respiratory Biology
Am. J. Respir. Crit. Care Med., June 1, 2006; 173(11): 1186 - 1193.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
K. Zaman, M. H. Hanigan, A. Smith, J. Vaughan, T. Macdonald, D. R. Jones, J. F. Hunt, and B. Gaston
Endogenous S-Nitrosoglutathione Modifies 5-Lipoxygenase Expression in Airway Epithelial Cells
Am. J. Respir. Cell Mol. Biol., April 1, 2006; 34(4): 387 - 393.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Biol.Home page
P. H. Yancey
Organic osmolytes as compatible, metabolic and counteracting cytoprotectants in high osmolarity and other stresses
J. Exp. Biol., August 1, 2005; 208(15): 2819 - 2830.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
F. Bourgeois, M. J Coady, and J.-Y. Lapointe
Determination of transport stoichiometry for two cation-coupled myo-inositol cotransporters: SMIT2 and HMIT
J. Physiol., March 1, 2005; 563(2): 333 - 343.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. W. Fewell, C. M. Smith, M. A. Lyon, T. P. Dumitrescu, P. Wipf, B. W. Day, and J. L. Brodsky
Small Molecule Modulators of Endogenous and Co-chaperone-stimulated Hsp70 ATPase Activity
J. Biol. Chem., December 3, 2004; 279(49): 51131 - 51140.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
F. L. M. Ricciardolo, P. J. Sterk, B. Gaston, and G. Folkerts
Nitric Oxide in Health and Disease of the Respiratory System
Physiol Rev, July 1, 2004; 84(3): 731 - 765.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
L. L. Clarke, L. R. Gawenis, T.-C. Hwang, N. M. Walker, D. B. Gruis, and E. M. Price
A domain mimic increases {Delta}F508 CFTR trafficking and restores cAMP-stimulated anion secretion in cystic fibrosis epithelia
Am J Physiol Cell Physiol, July 1, 2004; 287(1): C192 - C199.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. Griese, J. Ramakers, A. Krasselt, V. Starosta, S. van Koningsbruggen, R. Fischer, F. Ratjen, B. Mullinger, R. M. Huber, K. Maier, et al.
Improvement of Alveolar Glutathione and Lung Function but Not Oxidative State in Cystic Fibrosis
Am. J. Respir. Crit. Care Med., April 1, 2004; 169(7): 822 - 828.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X.-M. Zhang, X.-T. Wang, H. Yue, S. W. Leung, P. H. Thibodeau, P. J. Thomas, and S. E. Guggino
Organic Solutes Rescue the Functional Defect in {Delta}F508 Cystic Fibrosis Transmembrane Conductance Regulator
J. Biol. Chem., December 19, 2003; 278(51): 51232 - 51242.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement